We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Pnl1.5
Pinealon Research
Mostly mechanism / observational
9 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Pinealon studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality studies published 2012–2026.
Based on 9 studies
Confidence
Low confidence
By outcome
Neuroprotection & brain agingA short peptide with neuroprotective signals in cells and animals under hypoxic/oxidative stress; evidence is thin, low-quality, and from a single group, with mixed (incl. prooxidant) findings. · Not established (no robust human data)
Mostly mechanism / observational4 studies
Cognitive function
Mostly mechanism / observational3 studies
Longevity & agingPromoted for 'biological age' improvement on the basis of weak human reports and proposed epigenetic gene regulation; long-term human safety largely unknown. · Not established
Too few graded studies3 studies
Active research area
3 studies in the last 5 years
201220192026
1Review2026
In plain English: This review integrates current mechanistic insights with orthopaedic relevance, emphasizing safety, efficacy, and future directions for responsible integration into musculoskeletal care.
Rahman OF, Lee SJ, Seeds WA. · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2026)
Recovery-enhancing agents such as epithalon, delta sleep-inducing peptide, and pinealon target circadian and mitochondrial regulators, and neuroactive peptides like selank, semax, and dihexa enhance brain-derived neurotrophic factor and HGF/c-Met pathways critical to neuroplasticity.
Although preclinical studies are promising, there is a current lack of clinical trials.
This review integrates current mechanistic insights with orthopaedic relevance, emphasizing safety, efficacy, and future directions for responsible integration into musculoskeletal care.
In plain English: Leu-Ile, Glu-Trp, Lys-Glu, Gly-Pro, Glu-Asp-Arg, Lys-Glu-Asp, Met-Glu-His-Phe-Pro-Gly-Pro short peptides are described as multitarget agents with a wide range of activity.
In plain English: The EDR peptide (Glu-Asp-Arg) has been previously established to possess neuroprotective properties.
Khavinson V, Linkova N, Kozhevnikova E, Trofimova S. · Molecules (2020)
Review from the originating group laying out the proposed mechanism of the EDR (Glu-Asp-Arg) peptide in neuroprotection
Proposes EDR enters cells and binds histones/RNA, altering the MAPK/ERK pathway and synthesis of proapoptotic (caspase-3, p53) and antioxidant (SOD2, GPX1) proteins
States EDR interferes with dendritic-spine elimination in Alzheimer's/Huntington's neuronal cultures and 'improves memory issues in elderly patients'
In plain English: Workers of locomotive brigades used preparation during two weeks (1 capsule containing 100 mkg of Pinealon 2 times a day). Pinealon application has improved parameters of biological age and indicators determining the effectiveness of adaptive reactions.
Nazimko VA, Morgul' EV, Petrova OA, Sheĭkhova RG, Kozina LS, Savenko MA, Lysenko DS. · Adv Gerontol (2012)
Small, open, uncontrolled human report in locomotive-brigade workers exposed to occupational stress
Used oral Pinealon capsules of 100 mcg twice daily for two weeks — the source of the only published human dosing reference
Claimed improved biological-age parameters and adaptive-reaction indicators
7Open-LabelCited 1×2015
In plain English: The preparations of "Pinealon" and "Vesugen" have had the significant anabolic effect.
Meshchaninov VN, Tkachenko EL, Zharkov SV, Gavrilov IV, Katyreva IuE. · Adv Gerontol (2015)
Small human study (32 people, aged 41-83) with polymorbidity and organic brain syndrome in remission, using Pinealon and Vesugen
Reported anabolic effects and slowed biological-age indicators, with Vesugen showing a more visible effect than Pinealon
Crucially also found prooxidant activity by chemiluminescence and a significant decrease in CD34+ haematopoietic markers — flagged as needing future study
8AnimalCited 3×2014
In plain English: in hypoxia of brain conditions Pinealon forwards the increase of the neurogenesis and the decrease neuroinflammatory reactions to a reference level.
Animal study: aged rats under acute hypoxic hypoxia, examining caspase-3 activity in brain and IL-6 / TNF in serum
Pinealon (Glu-Asp-Arg) was associated with increased neurogenesis and a decrease in neuroinflammatory reactions toward reference levels under brain hypoxia
Compared against Cortexin, which reduced programmed cell death but kept IL-6 elevated
9Open-Label2016
In plain English: The most pronounced positive impact on indicators of biological age were detected during the combined use of these two Oligopeptide complexes.